Publicacións (31) Publicacións de JOSÉ RAMÓN JARABO SARCEDA

2024

  1. Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers

    Biomedicines, Vol. 12, Núm. 3

  2. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1647-1663

2023

  1. Implementation of a perioperative care App in elective thoracic surgery

    Cirugia Espanola, Vol. 101, Núm. 4, pp. 265-273

  2. Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

    Biomedicines, Vol. 11, Núm. 12

  3. The Use of Fissios App© as a Complement to a Face-to-Face Respiratory Physiotherapy Program versus an Attendance-Only Face-to-Face Physiotherapy Program in Patients Scheduled for Thoracic Surgical Procedures Reduces the Risk of Developing Postoperative Pulmonary Complications—A Quasi-Experimental Study

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  4. Tratamiento quirúrgico en cáncer de pulmón

    Revisiones en Cancer, Vol. 37, Núm. 3, pp. 121-132

2022

  1. Preoperative detection and evaluation of the need for psychological intervention in cancer and non-cancer patients referred to thoracic surgery

    Cirugia Espanola, Vol. 100, Núm. 6, pp. 359-366

  2. Thoracic surgery in Spain

    Journal of Thoracic Disease, Vol. 14, Núm. 3, pp. 779-787

2021

  1. Lung cancer patients with COVID-19 in Spain: GRAVID study

    Lung Cancer, Vol. 157, pp. 109-115

  2. Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges

    Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025

2020

  1. Immunotherapy moves to the early-stage setting in non-small cell lung cancer: Emerging evidence and the role of biomarkers

    Cancers, Vol. 12, Núm. 11, pp. 1-21

  2. Recommendations for acting in elective and urgent thoracic surgery during SARS-CoV-2 pandemic. Spanish Society of Thoracic Surgery

    Cirugia Espanola, Vol. 98, Núm. 10, pp. 574-581

2018

  1. Abordaje quirúrgico del paciente con carcinoma broncogénico y metástasis única pulmonar

    Revista de Patologia Respiratoria

  2. Cirugía de las metástasis pulmonares de sarcomas. Racional de la cirugía. Impacto en supervivencia

    Revisiones en Cancer, Vol. 32, Núm. 2, pp. 121-130

  3. Combined Hepatic and Pulmonary Metastasectomies From Colorectal Carcinoma. Data From the Prospective Spanish Registry 2008–2010

    Archivos de Bronconeumologia, Vol. 54, Núm. 4, pp. 189-197

  4. Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis

    European Journal of Surgical Oncology, Vol. 44, Núm. 7, pp. 1006-1012

2016

  1. Causal Model of Survival after Pulmonary Metastasectomy of Colorectal Cancer: A Nationwide Prospective Registry

    Annals of Thoracic Surgery, Vol. 101, Núm. 5, pp. 1883-1890

  2. Neumotórax, hemotórax y quilotórax

    Neumología clínica (Elsevier España), pp. 684-692

  3. Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR)

    Annals of Oncology, Vol. 27, Núm. 5, pp. 850-855

2015

  1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338